Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Tykocinski

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cellular Physiology|November 1, 1993
C-FMS dependent HL-60 cell differentiation and regulation of RB gene expressionA Yen, M E Forbes, S Varvayanis, et al.
Immunity|October 1, 1994
Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysisJ H Huang, R R Getty, F V Chisari, et al.
Cancer Research|November 24, 2001
Induction of antitumor immunity via intratumoral tetra-costimulator protein transferG Zheng, A Chen, R E Sterner, et al.
Cellular Immunology|July 11, 2006
CTLA-4.FasL inhibits allogeneic responses in vivoM Dranitzki-Elhalel, J-H Huang, J Rachmilewitz, et al.
Indian Journal of Biochemistry & Biophysics|February 1, 1994
Gene therapy of rat brain glioblastoma by an episome-based transcriptional cassette expressing antisense IGF-I cDNAT R Johnson, J Trojan, D D Anthony, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell cloneJ E Hambor, C A Hauer, H K Shu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 31, 1999
Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancerV Tanos, D Prus, S Ayesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1cD H Geho, J D Fayen, R M Jackman, et al.
Journal of Cellular Biochemistry|August 31, 2001
Properties of exogenously added GPI-anchored proteins following their incorporation into cellsD R Premkumar, Y Fukuoka, D Sevlever, et al.
The Journal of Clinical Investigation|April 1, 1988
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitroN K Cheung, E I Walter, W H Smith-Mensah, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cellular Physiology|November 1, 1993
C-FMS dependent HL-60 cell differentiation and regulation of RB gene expressionA Yen, M E Forbes, S Varvayanis, et al.
Immunity|October 1, 1994
Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysisJ H Huang, R R Getty, F V Chisari, et al.
Cancer Research|November 24, 2001
Induction of antitumor immunity via intratumoral tetra-costimulator protein transferG Zheng, A Chen, R E Sterner, et al.
Cellular Immunology|July 11, 2006
CTLA-4.FasL inhibits allogeneic responses in vivoM Dranitzki-Elhalel, J-H Huang, J Rachmilewitz, et al.
Indian Journal of Biochemistry & Biophysics|February 1, 1994
Gene therapy of rat brain glioblastoma by an episome-based transcriptional cassette expressing antisense IGF-I cDNAT R Johnson, J Trojan, D D Anthony, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell cloneJ E Hambor, C A Hauer, H K Shu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 31, 1999
Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancerV Tanos, D Prus, S Ayesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1cD H Geho, J D Fayen, R M Jackman, et al.
Journal of Cellular Biochemistry|August 31, 2001
Properties of exogenously added GPI-anchored proteins following their incorporation into cellsD R Premkumar, Y Fukuoka, D Sevlever, et al.
The Journal of Clinical Investigation|April 1, 1988
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitroN K Cheung, E I Walter, W H Smith-Mensah, et al.
Pageof 6